Výsledky vyhledávání

Akademický článek

A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE

Publikováno v: Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)

Abstract In this phase II, single arm trial (ACTRN12617000720314), we investigate if alternating osimertinib and gefitinib would delay the development of resistance to osimertinib in advanced, non-small cell lung cancer (NSCLC) with the epidermal gro

Externí odkaz: https://doaj.org/article/2aee772d175142968edb2117d86331be

Zobrazit plný text záznamu

Akademický článek

Feasibility and efficacy of a multicomponent exercise medicine programme in patients with pancreatic cancer undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial

Autor: Hao Luo, Robert U Newton, Daniel A Galvão, Dennis R Taaffe, Nigel Spry, Colin Tang, Kevin Jasas, Mikael Johansson, Ian Yusoff

Publikováno v: BMJ Open Gastroenterology, Vol 8, Iss 1 (2021)

Introduction Exercise is emerging as a therapy in oncology for its physical and psychosocial benefits and potential effects on chemotherapy tolerability and efficacy. However, evidence from randomised controlled trials (RCTs) supporting exercise in p

Externí odkaz: https://doaj.org/article/1468913232ce4a3ea087f7884973a791

Zobrazit plný text záznamu

Evaluation of a Clinic-Based Exercise Program in Patients with Pancreatic Cancer Undergoing Nonsurgical Treatment

Autor: HAO LUO, DANIEL A. GALVÃO, ROBERT U. NEWTON, COLIN I. TANG, NICOLAS H. HART, FAVIL SINGH, ANDREW DEAN, KEVIN JASAS, MIKAEL JOHANSSON, IAN YUSOFF, NIGEL SPRY, DENNIS R. TAAFFE

Publikováno v: Medicine and science in sports and exercise. 55(1)

Evidence regarding the role of exercise in pancreatic cancer (PanCa) is limited and is derived exclusively under tightly controlled research conditions. This study aimed to quantify adherence, adverse events, and changes in physical and psychological

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae30aa3b63aa44eeb39fa4e091b28c82
https://pubmed.ncbi.nlm.nih.gov/35941522

Zobrazit plný text záznamu

Patterns of care for stage III non–small cell lung cancer in Australia

Autor: Rina Hui, Ina Nordman, Rohit Joshi, Sara McLaughlin‐Barrett, Bryan A. Chan, Steven Kao, Fiona Hegi-Johnson, Emily Stone, Brett G.M. Hughes, Phillip Parente, Kevin Jasas

Publikováno v: Asia-Pacific Journal of Clinical Oncology. 15:93-100

Stage III non-small cell lung cancer (NSCLC) makes up a third of all NSCLC cases and is potentially curable. Despite this 5-year survival rates remain between 15% and 20% with chemoradiation treatment alone given with curative intent. With the recent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a7732fbf69f20748de174b5acfcba12
https://doi.org/10.1111/ajco.13140

Zobrazit plný text záznamu

Plný text ve formátu HTML

Autor: Nigel Spry, Ian F. Yusoff, Daniel A. Galvão, Dennis R. Taaffe, Andrew Dean, Colin Tang, Kevin Jasas, Hao Luo, Mikael Johansson, Robert U. Newton

Publikováno v: BMJ Open Gastroenterology
BMJ Open Gastroenterology, Vol 8, Iss 1 (2021)

IntroductionExercise is emerging as a therapy in oncology for its physical and psychosocial benefits and potential effects on chemotherapy tolerability and efficacy. However, evidence from randomised controlled trials (RCTs) supporting exercise in pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0b5bcd54989bfa72cca89de4a19350
https://doi.org/10.1136/bmjgast-2021-000642

Zobrazit plný text záznamu

Exercise as Medicine in the Management of Pancreatic Cancer

Autor: Mikael Johansson, Prue Cormie, Kevin Jasas, Ian F. Yusoff, Nigel Spry, Robert U. Newton, Daniel A. Galvão

Publikováno v: ResearcherID

CORMIE, P., N. SPRY, K. JASAS, M. JOHANSSON, I. F. YUSOFF, R. U. NEWTON, and D. A. GALVAO. Exercise as Medicine in the Management of Pancreatic Cancer: A Case Study. Med. Sci. Sports Exerc., Vol. 46, No. 4, pp. 664-670, 2014. Introduction :G iven the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcc2189e18ed767b04738299a70dfb46
https://doi.org/10.1249/mss.0000000000000160

Zobrazit plný text záznamu

Small cell lung cancer presenting with paraneoplastic limbic encephalitis

Autor: Samantha Bowyer, Michael Millward, Suzanne Webb, Kevin Jasas, David Blacker, Anna K. Nowak

Publikováno v: Asia-Pacific Journal of Clinical Oncology. 7:180-184

We report two cases of the rare neurological paraneoplastic syndrome, limbic encephalitis, as the initial presentation of small cell lung cancer. The first case responded to treatment of the underlying malignancy, while the second required more acute

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7db514b073aa883dd8ada8b3bc28d4e5
https://doi.org/10.1111/j.1743-7563.2010.01374.x

Zobrazit plný text záznamu

A multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancer

Autor: Peter M. Ellis, Colum Smith, R. Nevin Murray, Glenwood D. Goss, Frank Beier, Charles Butts, Guy Ely, Andrew Maksymiuk, Denis Soulières, Kevin Jasas

Publikováno v: Clinical lung cancer. 11(6)

Introduction: BLP25 liposome vaccine (L-BLP25) is an innovative therapeutic cancer vaccine designed to induce an immune response resulting in elimination of tumor cells expressing the MUC1 antigen, which is overexpressed in non–small-cell lung canc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7e9668b3b0eebcf524a30aca014b4d
https://pubmed.ncbi.nlm.nih.gov/21071331

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání